Golden N L, Kuhnert B R, Sokol R J, Martier S, Bagby B S
Am J Obstet Gynecol. 1984 Feb 1;148(3):254-9. doi: 10.1016/s0002-9378(84)80063-0.
Phencyclidine, a frequently abused drug, has been shown to cross the placenta and may cause harmful effects in the fetus. Therefore, a prospective study was undertaken to determine the extent of phencyclidine use during pregnancy. Two thousand three hundred twenty-seven pregnant women were screened for phencyclidine use by questionnaire and enzyme-mediated immunoassay technique urine testing. Nineteen women were identified as using phencyclidine during pregnancy and 149 were past users. Women with a history of phencyclidine use were compared with a population sample of nonusers. Phencyclidine users were more likely to be white; they were also younger and of lesser parity than nonusers. The majority had a history of multiple drug abuse. Although 7.3% of the population gave a history of phencyclidine use and 0.8% were found to use the drug during pregnancy, these figures are believed to underestimate the problem.
苯环己哌啶是一种经常被滥用的药物,已被证明可穿过胎盘并可能对胎儿产生有害影响。因此,开展了一项前瞻性研究以确定孕期苯环己哌啶的使用情况。通过问卷调查和酶介导免疫分析技术进行尿液检测,对2327名孕妇进行了苯环己哌啶使用情况筛查。19名女性被确定在孕期使用苯环己哌啶,149名是既往使用者。将有苯环己哌啶使用史的女性与非使用者的人群样本进行比较。苯环己哌啶使用者更可能是白人;他们也比非使用者更年轻且生育次数更少。大多数人有多种药物滥用史。尽管7.3%的人群有苯环己哌啶使用史,且0.8%的人被发现在孕期使用该药物,但这些数字据信低估了该问题。